Clinical activity of ponatinib in patients with chronic myeloid leukemia in chronic phase with e1a2 transcripts

類似資料

• The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia
  著者:: Nazha, Aziz, 等
  出版事項: (2013)
• Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor
  著者:: Sanford, David, 等
  出版事項: (2015)
• Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study
  著者:: Jain, Preetesh, 等
  出版事項: (2015)
• Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia – a propensity score analysis
  著者:: Sasaki, Koji, 等
  出版事項: (2016)
• Chronic myeloid leukemia: sequencing of TKI therapies
  著者:: Cortes, Jorge, 等
  出版事項: (2016)